Concepedia
Statistics
Publications
9
Citations
645
H-Index
Active since
2013
Affiliations
Inserm(Current)
Université Claude Bernard Lyon 1
Centre de Recherche en Cancérologie de Lyon
Hospices Civils de Lyon
Centre National de la Recherche Scientifique
Julien Bollard is an author at Inserm specializing in medicine, oncology, and molecular oncology.
Publications per year
2013–2023
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma
Julien Bollard, Verónica Miguela, Marina Ruiz de Galarreta et al. · Gut · 2016 · 297 citations · Full text
Medicine, Oncology, Pharmacology +17
An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling
Zoi Karoulia, Yang Wu, Tamer A. Ahmed et al. · Cancer Cell · 2016 · 213 citations · Full text
Medicine, Molecular Biology, Oncology +14
Antitumor Effect of Everolimus in Preclinical Models of High-Grade Gastroenteropancreatic Neuroendocrine Carcinomas
Julien Bollard, Christophe Couderc, Martine Blanc et al. · Neuroendocrinology · 2013 · 33 citations · Full text
The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors
Julien Bollard, Patrick Massoma, Cécile Vercherat et al. · Oncotarget · 2015 · 25 citations · Full text
Medicine, Cancer Biology, Oncology +17
Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors
Noura Benslama, Julien Bollard, Cécile Vercherat et al. · Investigational New Drugs · 2016 · 22 citations
Medicine, Oncology, Pathology +14
1–5 of 9